Armata Pharmaceuticals Inc. (NYSE AMERICAN : ARMP) Stock Information | RedChip

Armata Pharmaceuticals Inc. (NYSE AMERICAN : ARMP)


$3.07
-0.0800 ( -2.54% ) 5.9K

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Market Data


Open


$3.07

Previous close


$3.15

Volume


5.9K

Market cap


$104.85M

Day range


$2.93 - $3.17

52 week range


$1.07 - $5.26

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 62 Aug 14, 2023
8-k 8K-related 14 Aug 14, 2023
ars Annual reports 1 Aug 03, 2023
def Proxies and info statements 6 Aug 03, 2023
pre Proxies and info statements 5 Jul 24, 2023
8-k 8K-related 13 Jul 19, 2023
3 Insider transactions 1 Jul 19, 2023
8-k 8K-related 18 Jul 11, 2023

Latest News